Adenocarcinoma of the cervix: should we treat it differently? - Wikidata - wikimedia - TriplyDB

Adenocarcinoma of the cervix: should we treat it differently?

Adenocarcinoma of the cervix: should we treat it differently?

http://www.wikidata.org/entity/Q38364617

about

Drug Delivery Approaches for the Treatment of Cervical Cancer Different Prognostic Implications of 18F-FDG PET Between Histological Subtypes in Patients With Cervical Cancer.Fertility-Sparing Options in Young Women with Cervical Cancer.Fertility-sparing surgery for uterine cervical cancer.Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.Clinical application of a rapid cervical cancer screening method: Folate receptor-mediated staining of cervical neoplastic epithelia.Findings of multiple HPV genotypes in cervical carcinoma are associated with poor cancer-specific survival in a Swedish cohort of cervical cancer primarily treated with radiotherapy.

P2860

Q26742026-DC1135F8-5A73-4EB4-B5AE-72108175B3A6 Q36664130-B1051D3D-8E3F-45A4-9F30-24FC89E855C9 Q38711498-07EB7B3D-41E7-4BA1-BB11-A6C5020AC6F8 Q38826070-4570D7B7-AA69-4845-87BC-038512B79832 Q40408952-39C938DB-6439-4AC8-A4CD-1A07D25CEBAB Q41076095-3E43836C-3479-445B-AAC0-F1A568AB8CE3 Q50196523-3F3A64DA-3F7F-4D0D-B82E-7A4AFCC12EDE Q55262186-26462498-298F-4768-8BE6-61851E96446D

P2860

Adenocarcinoma of the cervix: should we treat it differently?

http://www.wikidata.org/entity/Q38364617

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Adenocarcinoma of the cervix: should we treat it differently?

@en

type

label

Adenocarcinoma of the cervix: should we treat it differently?

@en

prefLabel

Adenocarcinoma of the cervix: should we treat it differently?

@en

P1433

Q38364617-9020F365-672C-4D80-AD8C-16F0E2E5860D

P1476

Q38364617-A4B1CF0B-DB31-4E4C-8DC5-FB34BF6BF845

P2093

Q38364617-13A5887C-F951-479B-B0EE-B68B4386E7F3

Q38364617-153519D6-F30A-4B6C-87A8-9BEC989A3675

Q38364617-8597800F-C9B1-4704-9262-3C09D851EB71

Q38364617-BEB3CCB2-AF56-4697-BCF3-7A639868363D

P2860

Q38364617-04F74DEB-04D2-45F0-BFA8-6AB91E1B3865

Q38364617-06DABD0E-8DC0-43A6-80DB-C3E17A3B0F41

Q38364617-1320226C-2458-41EE-BCE9-F594CC461485

Q38364617-18BA2164-3545-4DFD-A4C9-781A3904A6E4

Q38364617-18EE0AE5-2F47-4402-9ECE-05A98737D467

Q38364617-19379BB2-A5B5-410D-A9B9-53E900F4E367

Q38364617-1C5F7F6E-B447-433A-BB8C-E1854213CD1D

Q38364617-225E6661-4729-40C7-BF3E-5ABB5263D9C1

Q38364617-23CBA789-384F-4E56-AB6B-1793A1695D16

Q38364617-2541E89B-8255-458E-8627-60E858574A64

P2888

Q38364617-97F5B4BB-4F1A-43AE-AFED-6AF637EFC873

P304

Q38364617-EE2A2A2B-F73B-4E0C-A1A0-04DB8C0EC1D9

P31

Q38364617-BBB9FFF0-7C10-480C-A36F-B6A4C98E1D72

P356

Q38364617-23A78F0F-3795-4FF2-85EE-F9A400AC413E

P433

Q38364617-44094A75-EC6F-4A85-A46C-C9B48BBC2212

P478

Q38364617-74158E06-BD89-4DD9-A2DB-0A785DDE6597

P577

Q38364617-B6844FD3-36E5-4498-99BE-5A6A074AD103

P5875

Q38364617-23EF72E1-B6D5-43FE-9368-5981B5725634

P6179

Q38364617-738D6CCB-0B90-4405-A7AE-CB24DE1D9538

P698

Q38364617-79626DD4-DA6C-44C6-ACE8-02DBDF72F011

P921

Q38364617-11584EF9-0A70-43DB-BDCC-28FC56578AB8

P356

S11912-015-0440-6

P1433

Current Oncology Reports

P1476

Adenocarcinoma of the cervix: should we treat it differently?

@en

P2093

David K Gaffney

http://www.w3.org/2001/XMLSchema#string

Elke A Jarboe

http://www.w3.org/2001/XMLSchema#string

Ned L Williams

http://www.w3.org/2001/XMLSchema#string

Theresa L Werner

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2014

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study.

Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma.

Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data.

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials.

Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies.

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

Improved survival with bevacizumab in advanced cervical cancer

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

P2888

s11912-015-0440-6

P304

17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11912-015-0440-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272843516

http://www.w3.org/2001/XMLSchema#string

P6179

1034859328

http://www.w3.org/2001/XMLSchema#string

P698

25708801

http://www.w3.org/2001/XMLSchema#string

P921